ABBVIE INC. share price logo

ABBVIE INC.

NASDAQ: ABBV

Mega Cap

$245.50

-5.44

(-2.17%)

Live

as on

ABBVIE INC. Stock Performance

as on August 4, 2026 at 1:11 am IST

  • Day's Low

    Day's High

    $244.88
    $256.00
    downward going graph

    0.25%

    Downside

    4.28%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $190.75
    $267.47
    downward going graph

    22.30%

    Downside

    8.95%

    Upside

    downward going graph

ABBVIE INC. share price movements today

Previous Close
$250.94
Open
$252.54
Volume
617.2K
Day's Low - High
$244.88 - $256.00
52 Week Low - High
$190.75 - $267.47

ABBVIE INC. Historical Returns

1 Month Return
-3.88 %
3 Month Return
+ 21.46 %
1 Year Return
+ 28.54 %
3 Year Return
+ 68.36 %
5 Year Return
+ 115.86 %

ABBVIE INC. Stock Fundamentals & Key Indicators

Check ABBVIE INC. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$443.4B

EPS (TTM)

14.0865

Dividend Yield

1.31%

Quarterly Earnings Growth YOY

2.90%

PE Ratio (TTM)

70.89

Industry PE ratio

23.38125

PEG Ratio

0.4131

EBITDA

30.8B

Revenue (TTM)

64.4B

Profit Margin

9.80%

Return On Equity TTM

62.25%

ABBVIE INC. Stock Valuation

Track how ABBVIE INC. P/E has moved over time to understand its valuation trends.

ABBVIE INC. in the last 5 years

  • Overview

  • Trends

Lowest (9.28x)

September 30, 2021

Industry (23.38x)

August 3, 2026

Today (70.89x)

August 3, 2026

Highest (22.78x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 70.89x

ABBVIE INC. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ABBVIE INC. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$443.4B115.86%70.899.80%1.31%
BUY$1.0T348.78%40.8134.99%0.54%
BUY$263.1B194.21%25.417.02%1.8900000000000001%
BUY$617.8B47%29.7721.48%2.0500000000000003%
BUY$307.2B70.4%36.6813.59%2.53%

Stock Returns calculator for ABBVIE INC. Stock including INR - Dollar returns

The ABBVIE INC. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

ABBVIE INC. investment value today

Current value as on today

₹1,36,735

Returns

₹36,735

(+36.73%)

Returns from ABBVIE INC. Stock

₹25,756 (+25.76%)

Dollar Impact

₹10,979 (+10.98%)

Analyst Recommendation on ABBVIE INC. Stock

Based on 35 analysts

BUY

65.71%

Buy

34.29%

Hold

0.00%

Sell

Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for ABBVIE INC.. Average target price of $270.39

ABBVIE INC. Share Price Target

Get share price movements and forecasts by analysts on ABBVIE INC..

What analysts predicted

9.21%UPSIDE

Target Price

$270.39

Current Price

$245.5

Analyzed by

35 Analysts

Target

$270.39

ABBVIE INC. target price $270.39, a slight upside of 9.21% compared to current price of $245.5. According to 35 analysts rating.

Indian Investors' Interest in ABBVIE INC. Stock

Investment in ABBVIE INC. Shares on INDmoney has dropped by -27.58% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-27.58% versus previous 30 day period

Search interest for ABBVIE INC. Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

ABBVIE INC. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
12,310
14,462
14,460
15,102
13,343
15,423
15,776
16,618
15,002
16,990
Gross Profit
8,216
10,260
10,248
10,706
9,341
11,077
10,472
12,066
10,784
14,388
Operating Income
2,798
3,998
3,831
-1,490
3,733
4,894
1,904
5,809
4,734
6,723
EBITDA
4,489
5,003
4,883
535
4,400
4,344
3,516
5,369
3,692
6,723
Interest Expense
660
726
720
702
700
740
739
714
717
679
Depreciation
2,074
2,131
2,079
2,102
2,039
2,050
2,063
1,987
1,936
-
Income Before Tax
1,755
2,146
2,084
-2,269
1,661
1,554
714
2,668
1,039
4,278
Income Tax Expense
383
773
520
-2,246
372
613
526
853
342
662
Net Income
1,369
1,370
1,561
-22
1,286
938
186
1,816
699
3,619
Net Profit Margin
11.12%
9.47%
10.80%
-0.15%
9.64%
6.08%
1.18%
10.93%
4.66%
21.30%

ABBVIE INC. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
25,638
28,216
32,753
33,266
45,804
56,197
58,054
54,318
56,334
61,160
Gross Profit
19,805
21,176
25,035
25,827
30,417
38,751
40,640
33,903
39,430
42,956
Operating Income
9,340
9,545
6,383
12,983
11,363
17,924
18,117
12,757
9,137
20,091
EBITDA
10,120
10,378
8,310
12,227
12,323
23,933
24,174
17,172
14,910
17,629
Interest Expense
1,047
1,150
1,348
1,784
2,454
2,423
2,230
2,224
2,808
2,893
Depreciation
-
1,501
1,765
2,017
6,471
8,521
8,467
8,698
8,386
8,139
Income Before Tax
7,884
7,727
5,197
8,426
3,398
12,989
13,477
6,250
3,716
6,597
Income Tax Expense
1,931
2,418
-490
544
-1,224
1,440
1,632
1,377
-570
2,364
Net Income
5,953
5,309
5,687
7,882
4,616
11,542
11,836
4,863
4,278
4,226
Net Profit Margin
23.22%
18.82%
17.36%
23.69%
10.08%
20.54%
20.39%
8.95%
7.59%
6.91%

ABBVIE INC. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
1,359
1,373
1,590
4,286
1,289
941
188
1,816
697
Operating Cash Flow
4,040
2,271
5,447
7,048
1,635
5,153
7,024
5,218
3,829
Investing Cash Flow
-9,588
-1,102
-8,256
-1,874
-735
-1,181
-3,264
-1,463
-574
Financing Cash Flow
10,819
-6,097
-3,072
-6,861
-1,258
-2,710
-4,590
-4,166
919
Change in Cash
5,253
-4,937
-5,873
-1,733
-349
1,292
-838
-400
4,162

ABBVIE INC. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
5,309
5,687
7,882
4,622
11,549
11,845
4,820
4,286
4,226
Operating Cash Flow
9,960
13,427
13,324
17,588
22,777
24,943
22,839
18,806
19,030
Investing Cash Flow
-274
-1,006
596
-37,557
-2,344
-623
-2,009
-20,820
-6,643
Financing Cash Flow
-5,512
-14,396
18,708
-11,501
-19,039
-24,803
-17,222
-5,211
-12,724
Change in Cash
4,203
-2,014
32,635
-31,475
1,297
-545
3,613
-7,290
-295

Mutual Funds that own ABBVIE INC. Stock

Check out the Mutual Funds with significant holdings in ABBVIE INC..

Global Institutional Holdings in ABBVIE INC.

Funds
Holdings
Goldman Sachs Group Inc
0.69%
Bank of New York Mellon Corp
0.75%
Morgan Stanley - Brokerage Accounts
2.15%
Vanguard Group Inc
10.23%
The Goldman Sachs Group Inc
0.86%

ABBVIE INC. News & Key Events

  • img

    Today's Timeline - 31 July

    Fri, 07:46 PM

    -

    AbbVie shares fall 2.01% after guidance cut despite strong Q2 earnings beat.

    Fri, 08:33 PM

    -

    AbbVie trims full-year EPS guidance due to Apogee acquisition, impacting stock sentiment.

    Fri, 08:34 PM

    -

    AbbVie raises full-year revenue outlook by $300 million despite EPS guidance cut due to Apogee acquisition.

  • img

    Today's Timeline - 31 July

    Fri, 10:20 PM

    -

    AbbVie reports Q2 2026 earnings, exceeding expectations with strong growth in immunology and neuroscience portfolios.

Insights on ABBVIE INC.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    AbbVie Inc. has shown positive revenue growth over the last two quarters. In the most recent quarter, the revenue increased from $15.00 billion to $16.99 billion, reflecting an average growth rate of 11.7% per quarter.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    AbbVie Inc. has shown strong profit growth over the last two quarters. In the most recent quarter, the company's net profit increased significantly from $699 million to $3.61 billion. This represents an average growth rate of 80.7% per quarter.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ABBV stock has moved up by 21.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 143.5% return, outperforming this stock by 75.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, AstraZeneca PLC has given 129.4% return, outperforming this stock by 100.9%

About ABBVIE INC.

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
OrganisationABBVIE INC.
Headquarters1 North Waukegan Road, North Chicago, IL, United States, 60064-6400
IndustryDrug Manufacturers - General
CEOMr. Robert A. Michael CPA
E-voting on sharesClick here to vote

Key Management of ABBVIE INC.

Name

Title

Mr. Wulff-Erik von Borcke

Senior VP & President of Oncology

Mr. Robert A. Michael CPA

CEO & Chairman of the Board

Dr. Roopal B. Thakkar M.D.

Executive VP of Research & Development and Chief Scientific Officer

Ms. Elizabeth Shea

Senior Vice President of Investor Relations

Mr. Perry C. Siatis

Executive VP, General Counsel & Secretary

Mr. Demetris D. Crum

Executive VP & Chief Human Resources Officer

Dr. Nicholas J. Donoghoe M.D.

Executive VP and Chief Business & Strategy Officer

Mr. Scott T. Reents

Executive VP & CFO

Mr. Jeffrey Ryan Stewart

Executive VP & Chief Commercial Officer

Ms. Linda Ray

Senior VP & Chief Information Officer

FAQs

What is ABBVIE INC. share price today?

ABBVIE INC. share price today is $245.50 as on . ABBVIE INC. share today touched a day high of $256.00 and a low of $244.88.

What is the 52 week high and 52 week low for ABBVIE INC. share?

ABBVIE INC. share touched a 52 week high of $267.47 on and a 52 week low of $190.75 on . ABBVIE INC. stock price today i.e. is trending at $245.50,which is 8.21% down from its 52 week high and 28.70% up from its 52 week low.

What is ABBVIE INC.'s market capitalisation today?

ABBVIE INC. market capitalisation is $0.44T as on .

How to invest in ABBVIE INC. Stock (ABBV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ABBVIE INC. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ABBVIE INC. Shares that will get you 0.0061 shares as per ABBVIE INC. share price of $245.50 per share as on August 3, 2026 at 7:41 pm IST.

What is the minimum amount required to buy ABBVIE INC. Stock (ABBV) from India?

Indian investors can start investing in ABBVIE INC. (ABBV) shares with as little as ₹95.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.35 in ABBVIE INC. stock (as per the Rupee-Dollar exchange rate as on ). Based on ABBVIE INC. share’s latest price of $245.50 as on August 3, 2026 at 7:41 pm IST, you will get 0.0407 shares of ABBVIE INC.. Learn more about fractional shares .

What are the returns that ABBVIE INC. has given to Indian investors in the last 5 years?

ABBVIE INC. stock has given 115.86% share price returns and 28.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?